Education
About Us
Working with TipRanks
Follow Us
Vbi Vaccines Inc (VBIVQ)
:VBIVQ
VBIVQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $1.35
Previous CloseN/A
Volume1.28K
Average Volume (3M)N/A
Market Cap
$14.34K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.34
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.92
Shares Outstanding178,257,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
VBI Vaccines News
VBIVQ FAQ
What was Vbi Vaccines Inc’s price range in the past 12 months?
Vbi Vaccines Inc lowest stock price was <$0.01 and its highest was $1.35 in the past 12 months.
What is Vbi Vaccines Inc’s market cap?
Vbi Vaccines Inc’s market cap is $14.34K.
When is Vbi Vaccines Inc’s upcoming earnings report date?
Vbi Vaccines Inc’s upcoming earnings report date is Mar 04, 2025 which is 158 days ago.
How were Vbi Vaccines Inc’s earnings last quarter?
Currently, no data Available
Is Vbi Vaccines Inc overvalued?
According to Wall Street analysts Vbi Vaccines Inc’s price is currently Overvalued.
Does Vbi Vaccines Inc pay dividends?
Vbi Vaccines Inc does not currently pay dividends.
What is Vbi Vaccines Inc’s EPS estimate?
Vbi Vaccines Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vbi Vaccines Inc have?
Vbi Vaccines Inc has 178,257,000 shares outstanding.
What happened to Vbi Vaccines Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vbi Vaccines Inc?
Among the largest hedge funds holding Vbi Vaccines Inc’s share is Perceptive Advisors LLC. It holds Vbi Vaccines Inc’s shares valued at 0.
Company Description
Vbi Vaccines Inc
VBI Vaccines Inc. is a biopharmaceutical company engaged in the development of vaccines to address unmet needs in infectious disease and immuno-oncology. Operating primarily within the pharmaceutical and biotechnology sectors, VBI Vaccines focuses on creating a range of preventative and therapeutic vaccines that leverage its proprietary enveloped virus-like particle (eVLP) platform technology. The company's core products include vaccines against hepatitis B and other infectious diseases, as well as therapeutic vaccines targeting cancer.
VBI Vaccines (VBIVQ) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
GlaxoSmithKline
―
Adaptimmune Therapeutics
―
Anixa Biosciences
―
Eton Pharmaceuticals
―
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---